MAZE insider transactions
Maze Therapeutics Inc. (MAZE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
MAZE insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Maze Therapeutics Inc., latest first. Follow anyone to get their next filing.
- Jason V ColomaChief Executive Officer, Director-$6.64M
- Harold BernsteinPresident, R&D & CMO-$9.19M
- Atul DandekarCsbo-$4.71M
- Phillips CourtneyGC and Corp. Secretary
- Sophie KornowskiDirector, since August 2026
- Paula A JohnsonDirector, since August 2026
- Daniel K SpiegelmanDirector
- Richard H SchellerDirector-$464K
- Jonathan E LimDirector
- Herve HoppenotDirector, since October 2025
- Charles J HomcyDirector
- Nancy C AndrewsDirector
- Amy BachrodtSVP, Finance-$1.33M
- Neil KumarDirector, since March 2026
- Catherine A. SohnDirector-$1.15M
- Third Rock Ventures IV, L.P.10% owner
- Sekar KathiresanDirector
- Neil ExterDirector
- Misbah TahirChief Financial Officer, since September 2025
Recent Form 3, 4, and 5 filings for MAZE
- Chief Executive Officer Coloma Jason V sold $1,043,766 worth of shares (34,501 units at $30.25) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- CSBO Dandekar Atul sold $240,532 worth of shares (7,500 units at $32.07) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Chief Executive Officer Coloma Jason V sold $932,260 worth of shares (34,501 units at $27.02) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- President, R&D & CMO Bernstein Harold exercised 16,141 shares at a strike of $10.42 and sold $434,743 worth of shares (16,141 units at $26.93) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- CSBO Dandekar Atul exercised 7,500 shares at a strike of $10.42 and sold $202,921 worth of shares (7,500 units at $27.06) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- President, R&D & CMO Bernstein Harold sold $254,502 worth of shares (9,705 units at $26.22) as part of a pre-agreed trading plan, closing all direct ownership in the company (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- GC and Corp. Secretary Courtney Phillips converted options into 11,000 shares (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Chief Executive Officer Coloma Jason V sold $906,999 worth of shares (34,501 units at $26.29) as part of a pre-agreed trading plan and converted options into 50,000 shares (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- CSBO Dandekar Atul converted options into 12,500 shares, increasing direct ownership by 48% to 38,750 units (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- President, R&D & CMO Bernstein Harold exercised 36,141 shares at a strike of $4.65 and sold $425,512 worth of shares (16,141 units at $26.36) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- CSBO Dandekar Atul sold $206,824 worth of shares (7,500 units at $27.58) as part of a pre-agreed trading plan and exercised 7,500 shares at a strike of $10.42 (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Director Kornowski Sophie4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Director Johnson Paula A4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 3 filed by new insider Kornowski Sophie3 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 3 filed by new insider Johnson Paula A3 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- President, R&D & CMO Bernstein Harold exercised 16,142 shares at a strike of $10.42 and sold $445,621 worth of shares (16,142 units at $27.61) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Chief Executive Officer Coloma Jason V sold $922,315 worth of shares (34,501 units at $26.73) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- CSBO Dandekar Atul exercised 7,500 shares at a strike of $10.42 and sold $205,031 worth of shares (7,500 units at $27.34) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- President, R&D & CMO Bernstein Harold exercised 14,609 shares at a strike of $10.42 and sold $436,864 worth of shares (14,609 units at $29.90) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Chief Executive Officer Coloma Jason V sold $1,034,253 worth of shares (34,501 units at $29.98) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- CSBO Dandekar Atul exercised 7,500 shares at a strike of $10.42 and sold $210,150 worth of shares (7,500 units at $28.02) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Chief Executive Officer Coloma Jason V sold $725,495 worth of shares (27,858 units at $26.04) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Director Spiegelman Daniel K4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Director Scheller Richard H4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Director Lim Jonathan E4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Director Hoppenot Herve4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Director Homcy Charles J4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Director Andrews Nancy C4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Chief Executive Officer Coloma Jason V sold $174,048 worth of shares (6,643 units at $26.20) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- President, R&D & CMO Bernstein Harold sold $381,112 worth of shares (14,853 units at $25.66) as part of a pre-agreed trading plan and exercised 14,853 shares at a strike of $10.42 (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- CSBO Dandekar Atul exercised 7,500 shares at a strike of $10.42 and sold $197,554 worth of shares (7,500 units at $26.34) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Chief Executive Officer Coloma Jason V sold $847,048 worth of shares (32,564 units at $26.01) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Chief Executive Officer Coloma Jason V sold $50,388 worth of shares (1,938 units at $26.00) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- President, R&D & CMO Bernstein Harold exercised 15,000 shares at a strike of $10.42 and sold $393,354 worth of shares (15,000 units at $26.22) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- CSBO Dandekar Atul exercised 14,305 shares at a strike of $10.42, increasing direct ownership by 136% to 24,808 units (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Director Homcy Charles J gifted 7,422 shares, decreasing direct ownership by 19% to 31,113 units (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- CSBO Dandekar Atul exercised 7,500 shares at a strike of $10.42 and sold $190,299 worth of shares (7,500 units at $25.37) as part of a pre-agreed trading plan (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Bernstein Harold4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Bachrodt Amy4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Dandekar Atul4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Kumar Neil4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 3 filed by new insider Kumar Neil3 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Bernstein Harold4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- President, R&D & CMO Bernstein Harold exercised 30,000 shares at a strike of $10.42 and sold $1,513,560 worth of shares (30,000 units at $50.45) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by GC and Corp. Secretary Courtney Phillips4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Coloma Jason V4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- President, R&D & CMO Bernstein Harold exercised 15,000 shares at a strike of $10.42 and sold $690,334 worth of shares (15,000 units at $46.02) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SVP, Finance Bachrodt Amy exercised 5,000 shares at a strike of $10.42 and sold $230,219 worth of shares (5,000 units at $46.04) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- CSBO Dandekar Atul exercised 7,500 shares at a strike of $10.42 and sold $331,990 worth of shares (7,500 units at $44.27) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SVP, Finance Bachrodt Amy exercised 5,000 shares at a strike of $10.42 and sold $227,612 worth of shares (5,000 units at $45.52) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- President, R&D & CMO Bernstein Harold exercised 25,156 shares at a strike of $10.42 and sold $1,011,299 worth of shares (25,156 units at $40.20) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Director Sohn Catherine A. exercised 29,413 shares at a strike of $10.42 and sold $1,149,054 worth of shares (29,413 units at $39.07) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- President, R&D & CMO Bernstein Harold exercised 4,844 shares at a strike of $10.42 and sold $195,668 worth of shares (4,844 units at $40.39) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SVP, Finance Bachrodt Amy exercised 5,000 shares at a strike of $10.42 and sold $195,754 worth of shares (5,000 units at $39.15) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- CSBO Dandekar Atul exercised 72,500 shares at a strike of $10.42 and sold $2,940,799 worth of shares (72,500 units at $40.56) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- President, R&D & CMO Bernstein Harold exercised 45,000 shares at a strike of $10.42 and sold $1,825,355 worth of shares (45,000 units at $40.56) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SVP, Finance Bachrodt Amy exercised 15,000 shares at a strike of $10.42 and sold $606,173 worth of shares (15,000 units at $40.41) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Director Homcy Charles J acquired 1,489 shares, increasing direct ownership by 5% to 31,113 units (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Large owner Third Rock Ventures Iv, L.P. disposed of 1,600,000 shares (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Director Homcy Charles J gifted 28,423 shares, decreasing direct ownership by 49% to 29,624 units (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)